Using a designated threshold, we also obtained 29 unique JMJD10 results that were underexpressed in several cancer types, i.e., breast, colorectal, head and neck, kidney, lung, lymphoma, pancreatic, sarcoma, and other cancers including adrenal cortex carcinoma and skin basal cell carcinoma. This evidence concerns the gene RIOX2 and lymphoma.